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Abstract
Background: Studies suggest that routine variations in public drinking water turbidity may be
associated with endemic gastrointestinal illness. We systematically reviewed the literature on this
topic.
Methods: We searched databases and websites for relevant studies in industrialized countries.
Studies investigating the association between temporal variations in drinking water turbidity and
incidence of acute gastrointestinal illness were assessed for quality. We reviewed good quality
studies for evidence of an association between increased turbidity and gastrointestinal illness.
Results: We found six relevant good quality studies. Of five studies investigating effluent water
turbidity, two found no association. Two studies from Philadelphia reported increased paediatric
and elderly hospital use on specific days after increased turbidity. A fifth study reported more
telephone health service calls on specific days after peak turbidity. There were differences between
studies affecting their comparability, including baseline turbidity and adjustment for seasonal
confounders.
Conclusion: It is likely that an association between turbidity and GI illness exists in some settings
or over a certain range of turbidity. A pooled analysis of available data using standard methods
would facilitate interpretation.
Background
Microbial or chemical contamination of drinking water
resulting from inadequate treatment at the plant or poor
control of the distribution system can cause acute gas-
trointestinal illness [1-3]. Turbidity, a measure of the light
refractiveness of water, is routinely used to indicate drink-
ing water quality. Although microbiological contamina-
tion is commonly accompanied by increases in turbidity,
other factors, including silt and organic matter, also affect
turbidity levels of water leaving the treatment plant [4].
Limits of acceptable turbidity for water leaving the treat-
ment plant vary between countries, but are generally
below 1 or 2 nephelometric turbidity units (NTU) [5-8];
most effluent turbidity readings are well below these lim-
its [9].
Outbreaks of gastrointestinal (GI) illness have been
linked to incidents in which turbidity exceeded acceptable
limits [10-16]. However, it is unclear whether endemic GI
illness is associated with drinking water within acceptable
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turbidity levels ('normal' turbidity). In 1997, Schwartz et
al. reported an association between variations in normal
drinking water turbidity and endemic GI illness in chil-
dren in Philadelphia [17]. The Environmental Protection
Agency (EPA) concluded that the study's results were
invalid, citing flaws in turbidity measurement and analy-
sis techniques [18,19]. Despite this, subsequent studies in
different settings have also suggested the existence of such
an association [15,20-24].
We were commissioned by the Drinking Water Inspector-
ate of England and Wales to determine what evidence
exists for an association between drinking water turbidity
and endemic GI illness in settings with public water sup-
plies similar to that in the United Kingdom (UK). We
report the findings of a systematic critical review to assess
the evidence for an association between turbidity levels of
public drinking water supplies within acceptable quality
limits and incidence of acute GI illness.
Methods
We searched for all peer-reviewed papers published before
December 2006 on the subject of water quality and dis-
eases or poisonings with acute GI manifestations in
PubMed, EMBASE, Aquatic Science and Fisheries
Abstracts 3: Aquatic Pollution and Environmental Qual-
ity, and Industrial and Applied Microbiological Abstracts
(Microbiology A) (see Appendix). We searched for non
peer-reviewed papers using the System for Information on
Grey Literature in Europe (SIGLE) and the following web-
sites: Water Intelligence Online http://www.waterintelli-
genceonline.com/, Health Canada http://www.hc-
sc.gc.ca/, Theses.com http://www.theses.com/, Theses
Canada http://www.collectionscanada.ca/thesescanada/,
and Proquest Digital Dissertations (for 2005 and 2006)
http://wwwlib.umi.com/dissertations/gateway. We man-
ually searched the reference lists of all papers that fulfilled
our eligibility criteria and checked our results with experts
in the field of drinking water quality.
Studies were included in the review if they investigated the
effect of variations in turbidity of water from a treated
public water supply (not a private well), either pre-treat-
ment or effluent (post-treatment and leaving the treat-
ment works), on the risk of acute GI illness in the
population(s) served by that supply. We restricted the
review to countries comparable to the UK in terms of
water supply infrastructure and incidence of acute GI ill-
ness: Western Europe, the United States, Canada, Japan,
Australia and New Zealand. Analyses comparing GI inci-
dence before and after a treatment works upgrade were
excluded, because system overhauls are one-time occur-
rences unrepresentative of the routine operation of the
treatment plant. Similarly, outbreak investigations were
excluded, since these events are unlikely to be representa-
tive of water quality generally. Intervention studies, where
homes were fitted with active or sham drinking water fil-
ters at the tap, were excluded as they did not investigate
the effect of turbidity specifically.
As exposure to drinking water in these settings is nearly
universal, the association between turbidity and GI illness
cannot easily be investigated using conventional epidemi-
ological studies. All the studies identified used time-series
approaches, in which the incidence of GI illness in a
defined population is observed over time and compared
at different levels of turbidity. Because such studies inves-
tigate the relationship between exposure and outcome
over time, adequate adjustment must be made in the anal-
ysis for temporal patterns in exposure and outcome (and
other relevant time-varying confounders such as tempera-
ture), in order to establish a causal rather than coinciden-
tal relationship.
Two reviewers (CCT, AGM) independently assessed each
study according to a list of pre-determined criteria regard-
ing appropriateness of the design and analysis, results and
interpretation, and overall quality. The merits of each
study, as compared with an optimum analysis, were dis-
cussed with two other reviewers (CDH, LCR) and summa-
rized in text form. Criteria for an optimum analysis were
as follows:
1. Exposure defined as daily turbidity at the treatment
plant, expressed as the mean of several repeat measure-
ments using standard equipment and units;
2. Outcome defined so as to minimize bias due to individ-
uals' perception of exposure (e.g. hospitalizations for GI
illness using International Classification of Diseases
(ICD) codes);
3. Attempts made to minimize misclassification of expo-
sure and outcome (e.g. using postcodes to match diag-
noses to the catchment population of a treatment plant);
4. Use of appropriate analytical methods, taking account
of seasonal variations in turbidity and acute GI illness,
and other potential (time-varying) confounders.
Important differences were found between studies in
terms of context and specification of analytical models.
We thus considered it inappropriate to conduct a pooled
analysis of study results.
Results
Of 22,687 papers retrieved, we found two eligible studies
investigating the association between GI illness and pre-
treatment water turbidity [20,21], and eight studies of
effluent water turbidity [15,17,21-26] (including Beau-
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deau et al. who studied both [21], [see Figure 1 and Addi-
tional File 1]).
Studies of pre-treatment water turbidity
Of the two pre-treatment water studies identified, the
study by Beaudeau et al. found no association and was
excluded, because of problems with exposure definition
and potential misclassification of both exposure and out-
come [see Additional File 2][21].
The remaining pre-treatment study, by Aramini et al.,
defined exposure as the mean daily turbidity of water
entering the treatment plant and the outcome as ICD-
coded admissions, accident and emergency (A&E), and
outpatient visits for acute GI illness, ascertained electron-
ically[20]. Postcodes were used to match illness to treat-
ment plant. Buffer zones, areas supplied by more than one
treatment plant, were excluded to reduce exposure mis-
classification. Time-series regression using multivariable
Poisson Generalised Additive Modelling (GAM) was used
to allow for non-linear associations between turbidity and
illness. Lags of up to 39 days for the effect of turbidity on
GI illness were investigated (to encompass incubation
periods of potential pathogens). An individual-level,
logistic regression approach was also used to investigate
temporal associations with turbidity among patients with
GI illness compared with control patients with respiratory
infections. Temporal exposure-response surface (TERS)
plots were used to visualize associations. Such plots are
three-dimensional surface graphs showing how the
model-predicted risk of the outcome varies with increas-
ing levels of the exposure at each lag; a flat or randomly
varying TERS plot suggests no effect of turbidity on GI ill-
ness over the lags tested, while peaks on the plot indicate
a consistent increase in incidence of GI illness over a spe-
cific range of turbidity at a specific time after that level of
turbidity was recorded at the treatment plant. The authors
took account of the most relevant confounders (long-term
time trends, season, day-of-week, public holidays, tem-
perature, and precipitation). Relative risks and odds ratios
between 1.2 and 2.0 for both time-series and individual-
level analyses were reported and several significant lags
were highlighted (Table 1). The authors estimated that
<2% of GI illness in areas of Vancouver served by the treat-
ment plants studied is attributable to drinking water.
Studies of effluent water turbidity
Of the eight eligible studies of effluent water turbidity, we
excluded three (Morris 1996,[15] Beadeau, [21] and Nau-
mova,[26] [see Additional File 2]). Problems with these
three studies included: exposure defined as mean turbid-
ity over more than one day (potentially masking daily
effects), [15,21] non-specific outcome definition,[21] no
geographic matching of outcome events to water sup-
ply,[15,21] and no adjustment for seasonal confounding
effects [21,26].
Five of the eligible effluent water studies met our criteria
for a good study [see Additional File 1] [17,22-25]. In all
of these, exposure was defined as mean daily turbidity at
the treatment plant. Four studies (Schwartz 1997,[17]
Morris 1998,[23] Schwartz 2000,[24] and Lim[25]) used
specific ICD codes for outcome definition, while Gilbert
used the less-specific measure of electronic records of calls
for certain GI symptoms to a telephone health line [see
Additional File 2][22]. Postcodes were used to match
diagnoses to treatment plant catchment areas in all five
studies. Lim et al. also excluded buffer zones[25]. The
studies used multivariable Poisson modelling, adjusting
for seasonal variations in turbidity and acute GI illness,
and other relevant potentially confounding factors (day-
of-week effects, [17,22-25] long-term trends, [17,24,25]
temperature, [17,24,25] and precipitation and public hol-
idays [22,25]). The two studies by Schwartz assumed a lin-
ear relationship between turbidity and illness,[17,24]
Summary of studies retrieved, 1966–2006Figure 1
Summary of studies retrieved, 1966–2006.
Potentially relevant to 
current analysis: n=88
Reasons for exclusion:
Reading full-text revealed they did not meet inclusion 
criteria: n=75
Outbreak investigations: n=2[14, 28]
Before and after analysis: n=2[10, 29]
Year-round boil-water advisory, therefore not 
relevant to developed country setting: n=2[30, 31]
Excluded: 
n=81
Included: 
n=9
Retrieved from full electronic 
search: n=22,687
Identified from correspondence 
with experts: n=2
Total from electronic search 
and consultation of experts: 
n=90
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while the other studies allowed for non-linear associa-
tions.
The five studies reported varying results (Table 1). Lim et
al. found no association [25]. Morris et al. (1998) did not
report significance tests, but presented TERS plots show-
ing no clear association between variations in turbidity
and illness at any particular lag [23]. Gilbert et al. reported
clear increases in calls for acute GI illness of between 33%
and 76% at around 11, 15, and 17 days after high turbid-
ity days, compared with the rate of calls the same number
of days after a mean turbidity day [22]. The two Schwartz
reports investigated the association of turbidity with pae-
diatric and elderly GI illness, respectively, using the same
turbidity data over the same time period. The authors esti-
mated that a 0.04 NTU increase in turbidity on any given
day resulted in up to a 31% increase in paediatric A&E vis-
its and admissions four to 10 days later,[17] and up to a
15% increase in elderly hospitalizations nine to 11 days
later [24].
Discussion
We have conducted the most comprehensive review of the
literature to date on the potential association between
drinking water turbidity and incidence of endemic GI ill-
ness. We found nine studies conducted in settings relevant
to the UK. Six of these were of sufficiently good quality to
provide evidence of an association.
Aramini et al., one of the six studies meeting minimum
quality criteria, investigated pre-treatment water turbidity
[20]. Water was disinfected, but not filtered, before leav-
ing the treatment works. The authors cited references
regarding the decreased disinfection efficiency that may
result from an increase in pre-treatment water turbidity
(because of precipitation, for example). It is difficult to
draw conclusions from this study, as the relationship
between pre-treatment and effluent water, and the rele-
vance of this as a measure of exposure, remains unclear;
pre-treatment water turbidity may not be a good indicator
of the quality of water leaving the plant.
Two of the five good-quality studies of effluent water tur-
bidity (Lim [25] and Morris 1998 [23]) found no associa-
tion, while the other three, two by Schwartz based on the
same turbidity data, [17,24] and the Gilbert study,[22]
found positive associations.
The Schwartz studies[17,24] were widely criticized by the
EPA and others [18,19], who raised objections regarding
the measurement of exposure and outcome, and the use
of turbidity as an indicator of microbiological contamina-
tion. Inclusion of factors not associated with microbial
content in the exposure would result in a 'noisy' proxy for
exposure and dilute or mask any existing effect on GI ill-
ness. However, turbidity is commonly used as a crude
measure of water quality and turbidity levels in breach of
quality limits are often associated with outbreaks of GI ill-
Table 1: Results reported in good quality studies
Study Effect measure (lag in 
brackets)
Over what unit 
of turbidity
Positive Lags (days) Measure of 
population impact
Schwartz, US (1997) [17] Between 5–31% increase in 
A&E visits and admissions at 
various lags.
0.04 NTU 1, 4, 6–7†, 7–9†, 8, 10, 13 None stated.
Morris, US (1998) [23] TERS plots suggest weak 
correlations; no statistical 
significance testing.
N/A None. N/A
Schwartz, US (2000) [24] Between 5–15% (9–11) 
increase in admissions; 4–6 
lag also significant for one 
plant; effect greater in those 
over 75 years (p < 0.0001)
0.035 NTU 4–6†, 9, 10, 11, 9–11† None stated.
Aramini, Canada (2000) [20] Relative rates and odds 
ratios between 1.2 and 2.0 
for different watershed/age 
combinations.
* 3–6†, 6–9†, 12–16†, 21–29† <2% GI illness estimated to 
be attributable to drinking 
water
Lim, Canada (2002) [25] No significant measures of 
effect reported.
N/A None. N/A
Gilbert, Canada (2006) [22] Relative rates of 1.33 (11), 
1.53 (15) and 1.76 (17).
* 11, 15, 17 None stated.
*A relative rate and odds ratio of, for example, 1.2 represents a 20% increase in the likelihood of gastroenteritis associated with a particular level of 
turbidity at a particular lag, compared to the predicted probability associated with the mean turbidity effect for that particular lag, after adjusting for 
other parameters in the model
†combined
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ness [10-15]. If normal turbidity levels can act as a proxy
for concentration of agents of GI illness, then this should
be reflected in the lags at which associations with hospital
admissions are found: chemicals and viruses should result
in associations at shorter lags than bacteria or parasites,
reflecting the relative incubation periods of these agents.
Schwartz et al. reported two such clusters of lags at four to
six and nine to 11 days, which they attributed to viral and
parasitic agents respectively. Gilbert et al. reported signifi-
cant lags (around 11, 15, and 17 days) at which increased
rates of GI-related calls clustered. Unfortunately, it is dif-
ficult to demonstrate that certain lags are associated with
specific agents, as GI-related ICD codes do not reliably dif-
ferentiate between different GI pathogens and calls to a
telephone health line are non-specific.
The EPA was also concerned that a large proportion of the
turbidity readings were below the calibration limit of tur-
bidity meters and that ICD codes potentially including
non-infectious GI illness were included in the outcome
definition. Although errors in turbidity measurement may
be more common below the calibration limit, these are
unlikely to be systematic and are reduced by using the
mean of several daily measurements, while inclusion of
GI events unrelated to exposure could dilute observed
associations, but is unlikely to result in spurious associa-
tions being found where none truly exist [27].
A further issue in time-series studies is that, because asso-
ciations are studied over multiple time lags between expo-
sure and disease, some positive associations could be
chance findings. Both the Schwartz and Gilbert studies
addressed this by focusing on clusters of consecutive lags
that predicted increases in GI hospitalizations, rather than
the statistical significance of individual lags. If no associa-
tion between turbidity and GI hospitalizations existed,
positive and negative coefficients would be observed with
an equal distribution across all lags tested, five percent of
which would be significant at a conventional level of pre-
cision simply by chance. The probability of positive asso-
ciations being observed over consecutive lags by chance is,
however, much reduced [27], making the positive correla-
tions observed by Schwartz and Gilbert unlikely to be
chance associations.
Differences between studies
Important differences were found between studies that
may affect the interpretation and comparability of their
results. Differences in the modelling strategy between
studies, particularly the degree of seasonal adjustment
employed, made studies difficult to compare. For exam-
ple, the study by Lim adjusted for precipitation, whereas
the Schwartz studies did not. However, it is unclear from
the studies whether this variable is an important con-
founder. Gilbert did not include precipitation in the final
model, after assessing goodness of fit of the model with
and without precipitation, suggesting that it may not be
an important confounder, at least in this setting. Adequate
seasonal adjustment should account for potential con-
founding effects arising from the fact that precipitation is
also seasonal. In addition, although rainfall may be bio-
logically related to both exposure and outcome, at least
part of its effect on GI illness will be through its effect on
turbidity, and adjusting for it may not be of benefit unless
other causal pathways exist.
Two other relevant questions are whether it is correct to
assume a linear association between increases in turbidity
and in GI illness (as done by Schwartz), and whether such
an assumption holds throughout the range of turbidity
and of incidence of GI illness. Indeed, mean turbidity in
the Lim study was very much lower (0.06 NTU) than in
the other studies (<0.3 NTU), but the range over which
effluent turbidity varied was similar in all studies (about
0.1 to 0.5 NTU). A plausible explanation is that increases
in turbidity levels around 0.06 NTU do not cause
increases in illness, while increases from higher baseline
turbidity levels do.
Conclusion
Associations between drinking water turbidity and GI ill-
ness have been found in two settings, in people of various
ages, but not in other settings. It is likely that studies
observed different results because of differences in the
mean turbidity level between settings. Important method-
ological differences, such as in the level of adjustment for
seasonal confounders, might also help to explain conflict-
ing results. An analysis of existing data using the same
modelling approach, or a pooled analysis of the raw data
from these and other settings, would facilitate a better
understanding of currently available findings.
Further studies could consider alternative indicators of
water quality; particle count data would improve the spe-
cificity of exposure definition, and could help differenti-
ate between bacterial and parasitic agents based on their
size, although it should be noted that non-pathogenic
organisms are routinely found in water. Such technology
is also more expensive and not widely available. Specifi-
city of exposure definition could also be improved
through the use of water quality data at different points in
the distribution system, which would better represent the
quality of water at the tap. Such data are, however, not eas-
ily available.
Finally, most studies did not estimate the proportion of
GI illness in the population attributable to turbidity. This
proportion depends on the magnitude of the turbidity
effect at a given lag, the range over which turbidity has an
effect, and the proportion of days for which turbidity is
BMC Public Health 2007, 7:256 http://www.biomedcentral.com/1471-2458/7/256
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within this range (prevalence of exposure). Studies of
drinking water are important because exposure is nearly
universal, such that even small effects on GI illness could
have considerable public health impact. Positive associa-
tions between drinking water quality and GI illness might
suggest that threshold limits of acceptable turbidity (or,
indeed, any other relevant measure of quality) should be
reconsidered. However, any changes to drinking water
regulations must be based not only on the demonstration
of an association with GI illness, but also on the realistic
impact that any regulatory changes would have on public
health – in terms of the number of cases and societal costs
averted – and the level of risk that is considered acceptable
from drinking water.
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Appendix
Search strategies
PubMed Search Strategy
Exposure
MeSH terms (separated by OR): Sanitation, Sewage,,
Water Microbiology, Water Supply, Water Purification,
Water Pollutants, Nephelometry and Turbidimetry, Water
Pollution, Sanitary Engineering, Corrosion, Hazardous
Substances
OR free text terms (separated by OR): water treat*, neph-
elomet*, turbid*, water source, water filt*, boil* water,,
tap water, water discolo*, water qualit*, water deteriorat*,
potable, corrosion by-product, corrosion by-product*,
waste water, toxi*
Outcome
MeSH terms (separated by OR): Gastrointestinal Diseases,
Cryptosporidiosis, Cryptosporidium, Giardiasis, Giardia,
Bacterial Infections, Virus Diseases,, Poisoning
OR free text terms (separated by OR): diarr*, stomach,
vomit*, waterborne, water-borne, water borne
Limit
Human
Restrict to
MeSH and related free-text terms (separated by OR): Can-
ada, United States, Japan, Europe, Australasia
Exclude
Asia, Siberia, Georgia (Republic), South America, Central
America, Africa, Mexico
EMBASE Search Strategy
Exposure
Exploded subject headings (separated by OR): Sewage
treatment, Sewage, Microbiology, Water Supply, Water
Management, Water Pollutant, Nephelometry, Water Pol-
lution, Corrosion
OR Free text terms (separated by OR): water treat$, neph-
elomet$, turbid$, water source$, water filt$, boil$ water,
tap water, water discolo$, water qualit$, water deteriorat$,
potable, corrosion by-product, waste water
AND
Outcome
Exploded subject headings (separated by OR): Gastroin-
testinal Disease, Cryptosporidiosis,, Cryptosporidium,
Cryptosporidium parvum, Giardiasis, Giardia, Giardia
lamblia, Virus Infection, Bacterial infection Intoxication,
OR Free text terms (separated by OR): diarr$, stomach$,
vomit$, waterborne, water-borne, water borne
Limit
Human
Restrict to
MeSH and related free-text terms (separated by OR): Can-
ada, United States, Japan, Europe, Australia and New Zea-
land
Exclude
Asia, South Asia, Southeast Asia, South America, Central
America, Africa, Mexico
Aquatic Science and Fisheries Abstracts 3: Aquatic Pollution and 
Environmental Quality and Industrial and Applied Microbiological 
Abstracts (Microbiology A) combined search strategy
Discolo* or turbid* or waterqualit* or drink*AND Gas-
trointestinal or diarr* (all free text terms)
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